CollPlant Receives Research and Development Project Approval From the Israel Innovation Authority to Advance its Collagen-based BioInk for 3D Printing of Tissues and Organs
CollPlant Biotechnologies Ltd. - Ordinary Shares (CLGN)
US:NASDAQ Investor Relations:
collplant.com/investor-relation
Company Research
Source: PR Newswire
Impact Snapshot
Event Time:
CLGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLGN alerts
High impacting CollPlant Biotechnologies Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
CLGN
News
- COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONPR Newswire
- Shareholders in CollPlant Biotechnologies (NASDAQ:CLGN) are in the red if they invested three years ago [Yahoo! Finance]Yahoo! Finance
- GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy [Yahoo! Finance]Yahoo! Finance
- CollPlant Issues Letter to Shareholders [Yahoo! Finance]Yahoo! Finance
- CollPlant Issues Letter to ShareholdersPR Newswire
CLGN
Earnings
- 11/29/23 - Miss
CLGN
Sec Filings
- 2/15/24 - Form 6-K
- 2/13/24 - Form SC
- 1/25/24 - Form SC
- CLGN's page on the SEC website